2018
$90M
from 6 investors over 6 rounds
Regor Therapeutics Group raised $90M on February 18, 2021
Investors: 祥恩股权投资管理(上海)有限公司, Lilly Asia Ventures, 泰福资本 TF Capital, 澜亭资本 and Loyal Valley Capital
Regor Therapeutics Group raised undisclosed on July 1, 2018
Investors: Qilu Pharmaceuticals